STOCK TITAN
  1. Home
  2. Sec-filings
  3. SXI
  4. [Form 4] Standex International Corporation Insider Trading Activity

Insider Sale: Standex Vice President/CFO Disposes 1,085 Shares at ~$209.86

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Ademir Sarcevic, Vice President/CFO/Treasurer and reporting person of Standex International Corp. (SXI), disclosed a sale of common stock on 08/26/2025. The filing reports the sale of 1,085 shares at a weighted-average sale price of $209.8642, with actual trade prices ranging from $209.175 to $210.41. After the transaction, the reporting person beneficially owns 11,164 shares, held directly. The Form 4 was signed and submitted on 08/28/2025.

Positive

  • None.

Negative

  • Sale of 1,085 shares by a named senior officer, reducing direct beneficial ownership to 11,164 shares
  • Insider disposition may be perceived negatively by some investors despite no additional context provided

Insights

TL;DR: Insider sale of 1,085 shares at ~$209.86 reduced direct holdings to 11,164 shares; appears to be a routine disposition.

The transaction is a straightforward open-market sale of common stock by a senior officer. The filing provides clear quantitative detail: 1,085 shares sold on 08/26/2025 at a weighted-average price of $209.8642 with execution prices between $209.175 and $210.41. Post-sale beneficial ownership is 11,164 shares held directly. No derivatives, grants, or acquisition plan references are included. For valuation context, the filing does not state total outstanding shares or percentage ownership, so market-impact conclusions cannot be drawn from this form alone.

TL;DR: Senior officer reported a disclosed sale; documentation meets Rule 16 reporting requirements with price-range disclosure.

The Form 4 discloses the officer relationship (Vice President/CFO/Treasurer) and indicates the sale was executed in multiple transactions with a disclosed weighted-average price and price range. The reporting person offers to provide transaction-level breakdowns upon request, which supports compliance and transparency. The filing does not reference any Rule 10b5-1 trading plan or indicate other coordinated reporting persons.

Insider Sarcevic Ademir
Role Vice President/CFO/Treasurer
Sold 1,085 shs ($228K)
Type Security Shares Price Value
Sale Common Stock 1,085 $209.8642 $228K
Holdings After Transaction: Common Stock — 11,164 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sarcevic Ademir
(Last) (First) (Middle)
23 KEEWAYDIN DRIVE
SUITE 300
(Street)
SALEM NH 03079
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President/CFO/Treasurer
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/26/2025 S 1,085 D $209.8642(1) 11,164 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $209.175 to $210.41, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
/s/ Alan J. Glass 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Ademir Sarcevic report in the Form 4 for Standex International (SXI)?

The filing reports a sale of 1,085 shares on 08/26/2025 at a weighted-average price of $209.8642, leaving 11,164 shares beneficially owned.

What price range was disclosed for the shares sold by the reporting person?

The shares were sold in multiple transactions at prices ranging from $209.175 to $210.41.

What is the reporting person's role at Standex International?

The reporting person is listed as Vice President/CFO/Treasurer and an officer of the issuer.

Was the transaction part of a 10b5-1 plan or an amendment noted?

The Form 4 does not indicate the transaction was made pursuant to a Rule 10b5-1 plan and does not show an amendment date other than the filing date.

When was the Form 4 signed and filed?

The filing shows a signature date of 08/28/2025.